Page last updated: 2024-10-15

2,3-diphosphoglycerate and Disease Exacerbation

2,3-diphosphoglycerate has been researched along with Disease Exacerbation in 2 studies

2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peng, Z1
Luo, R1
Xie, T1
Zhang, W1
Liu, H1
Wang, W1
Tao, L1
Kellems, RE1
Xia, Y1
Giral, P1
Rosenbaum, D1

Other Studies

2 other studies available for 2,3-diphosphoglycerate and Disease Exacerbation

ArticleYear
Erythrocyte Adenosine A2B Receptor-Mediated AMPK Activation: A Missing Component Counteracting CKD by Promoting Oxygen Delivery.
    Journal of the American Society of Nephrology : JASN, 2019, Volume: 30, Issue:8

    Topics: 2,3-Diphosphoglycerate; Adult; AMP-Activated Protein Kinases; Angiotensin II; Animals; Disease Progr

2019
Retinopathy progression in type 2 diabetes.
    The New England journal of medicine, 2010, 11-25, Volume: 363, Issue:22

    Topics: 2,3-Diphosphoglycerate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Fenofi

2010